This has led to the view that tau pathology is more directly linked with cognitive impairments in AD than Aβ, though the truth is likely more complicated (Bloom, 2014; Maass et al., 2018; Sperling et al., 2019). This evidence concerns the gene MAPT and Alzheimer disease.